Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.

The success of Haematopoietic cell transplantation (HCT) is often limited by regimen-related toxicity (RRT) caused by conditioning regimen drugs. Among different conditioning drugs, busulfan (Bu) and treosulfan (Treo), although widely used in HCT, exhibit different toxicity profiles, the mechanism o...

Full description

Saved in:
Bibliographic Details
Main Authors: Balaji Balakrishnan, Raveen Stephen Stallon Illangeswaran, Bharathi Murugan Rajamani, Arun Kumar Arunachalam, Aswin Anand Pai, Ezhilpavai Mohanan, Alok Srivastava, Vikram Mathews, Poonkuzhali Balasubramanian
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0293311&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850116561670504448
author Balaji Balakrishnan
Raveen Stephen Stallon Illangeswaran
Bharathi Murugan Rajamani
Arun Kumar Arunachalam
Aswin Anand Pai
Ezhilpavai Mohanan
Alok Srivastava
Vikram Mathews
Poonkuzhali Balasubramanian
author_facet Balaji Balakrishnan
Raveen Stephen Stallon Illangeswaran
Bharathi Murugan Rajamani
Arun Kumar Arunachalam
Aswin Anand Pai
Ezhilpavai Mohanan
Alok Srivastava
Vikram Mathews
Poonkuzhali Balasubramanian
author_sort Balaji Balakrishnan
collection DOAJ
description The success of Haematopoietic cell transplantation (HCT) is often limited by regimen-related toxicity (RRT) caused by conditioning regimen drugs. Among different conditioning drugs, busulfan (Bu) and treosulfan (Treo), although widely used in HCT, exhibit different toxicity profiles, the mechanism of which is still unclear. Here we investigated the effects of Bu and Treo in endothelial cells. While both Bu and Treo induced DNA damage in endothelial cells, we observed Bu alone to induce oxidative stress and sustained activation of phospho-ERK1/2, leading to apoptosis. However, Treo-treated cells exhibited no oxidative stress/apoptosis of endothelial cells. Screening of pharmacological inhibitors of both ROS and p-ERK revealed that metformin effectively ameliorates Bu-mediated toxicity in endothelial cells. In Balb/c mice, we observed a significant reduction in bone marrow endothelial cells in Bu-treated mice compared to Treo-treated mice. Further, liver sinusoidal endothelial cells (LSEC) was damaged by Bu, which is implicated in liver vasculature and their functional capacity to uptake FITC-albumin. However, Treo-treated mice liver vasculature was morphologically and functionally normal. When mice were pretreated with metformin followed by Bu, LSECs damage was ameliorated morphologically and functionally. Bone marrow transplants done on these mice did not affect the engraftment of donor cells.
format Article
id doaj-art-a6f9b91b71b042d9bb4e07d1011f99de
institution OA Journals
issn 1932-6203
language English
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-a6f9b91b71b042d9bb4e07d1011f99de2025-08-20T02:36:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-011810e029331110.1371/journal.pone.0293311Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.Balaji BalakrishnanRaveen Stephen Stallon IllangeswaranBharathi Murugan RajamaniArun Kumar ArunachalamAswin Anand PaiEzhilpavai MohananAlok SrivastavaVikram MathewsPoonkuzhali BalasubramanianThe success of Haematopoietic cell transplantation (HCT) is often limited by regimen-related toxicity (RRT) caused by conditioning regimen drugs. Among different conditioning drugs, busulfan (Bu) and treosulfan (Treo), although widely used in HCT, exhibit different toxicity profiles, the mechanism of which is still unclear. Here we investigated the effects of Bu and Treo in endothelial cells. While both Bu and Treo induced DNA damage in endothelial cells, we observed Bu alone to induce oxidative stress and sustained activation of phospho-ERK1/2, leading to apoptosis. However, Treo-treated cells exhibited no oxidative stress/apoptosis of endothelial cells. Screening of pharmacological inhibitors of both ROS and p-ERK revealed that metformin effectively ameliorates Bu-mediated toxicity in endothelial cells. In Balb/c mice, we observed a significant reduction in bone marrow endothelial cells in Bu-treated mice compared to Treo-treated mice. Further, liver sinusoidal endothelial cells (LSEC) was damaged by Bu, which is implicated in liver vasculature and their functional capacity to uptake FITC-albumin. However, Treo-treated mice liver vasculature was morphologically and functionally normal. When mice were pretreated with metformin followed by Bu, LSECs damage was ameliorated morphologically and functionally. Bone marrow transplants done on these mice did not affect the engraftment of donor cells.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0293311&type=printable
spellingShingle Balaji Balakrishnan
Raveen Stephen Stallon Illangeswaran
Bharathi Murugan Rajamani
Arun Kumar Arunachalam
Aswin Anand Pai
Ezhilpavai Mohanan
Alok Srivastava
Vikram Mathews
Poonkuzhali Balasubramanian
Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.
PLoS ONE
title Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.
title_full Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.
title_fullStr Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.
title_full_unstemmed Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.
title_short Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.
title_sort metformin pretreatment ameliorates busulfan induced liver endothelial toxicity during haematopoietic stem cell transplantation
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0293311&type=printable
work_keys_str_mv AT balajibalakrishnan metforminpretreatmentamelioratesbusulfaninducedliverendothelialtoxicityduringhaematopoieticstemcelltransplantation
AT raveenstephenstallonillangeswaran metforminpretreatmentamelioratesbusulfaninducedliverendothelialtoxicityduringhaematopoieticstemcelltransplantation
AT bharathimuruganrajamani metforminpretreatmentamelioratesbusulfaninducedliverendothelialtoxicityduringhaematopoieticstemcelltransplantation
AT arunkumararunachalam metforminpretreatmentamelioratesbusulfaninducedliverendothelialtoxicityduringhaematopoieticstemcelltransplantation
AT aswinanandpai metforminpretreatmentamelioratesbusulfaninducedliverendothelialtoxicityduringhaematopoieticstemcelltransplantation
AT ezhilpavaimohanan metforminpretreatmentamelioratesbusulfaninducedliverendothelialtoxicityduringhaematopoieticstemcelltransplantation
AT aloksrivastava metforminpretreatmentamelioratesbusulfaninducedliverendothelialtoxicityduringhaematopoieticstemcelltransplantation
AT vikrammathews metforminpretreatmentamelioratesbusulfaninducedliverendothelialtoxicityduringhaematopoieticstemcelltransplantation
AT poonkuzhalibalasubramanian metforminpretreatmentamelioratesbusulfaninducedliverendothelialtoxicityduringhaematopoieticstemcelltransplantation